ALFA Filings
Every announcement, straight from the exchange
Every Genpharmasec other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Genpharmasec Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing provides a standard breakdown of promoter and public shareholding.
Genpharmasec Limited filed its Annual Secretarial Compliance Report for FY 2025-26. The auditor reported full compliance with SEBI regulations, noting no material deviations or penalties.
Genpharmasec Ltd submitted its quarterly certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The Registrar and Share Transfer Agent, Satellite Corporate Services, confirmed that no physical share certificates were received for dematerialization during the quarter. This is a routine compliance disclosure.